Oxaliplatina CAS：61825-94-3

Visão geral do produto

This comprehensive guide provides an in-depth analysis of Oxaliplatin CAS:61825-94-3, a chemotherapy drug widely used in the treatment of various types of cancer. The article aims to offer a detailed understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, thereby assisting users in making informed decisions.

Resumo do produto

This article offers a detailed overview of Oxaliplatin CAS:61825-94-3, a chemotherapy drug used in the treatment of cancer. It covers various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. The guide aims to assist users in understanding the drug's benefits, potential side effects, and appropriate usage.

Parâmetros do produto

Oxaliplatin CAS:61825-94-3 is a platinum-based chemotherapy drug used in the treatment of colorectal cancer, ovarian cancer, and other types of cancer. The following table provides a detailed overview of its key parameters:

```html

```

Cenários de utilização

Oxaliplatin CAS:61825-94-3 is primarily used in the treatment of colorectal cancer, ovarian cancer, and other types of cancer. It is often combined with other chemotherapy drugs to enhance its efficacy. The following table provides a summary of its usage scenarios:

```html

```

Estudos de caso

The following case studies highlight the effectiveness of Oxaliplatin CAS:61825-94-3 in treating various types of cancer:

1. **Colorectal Cancer**: A patient with metastatic colorectal cancer received Oxaliplatin in combination with 5-FU and leucovorin. The treatment resulted in a significant reduction in tumor size and improved overall survival.

2. **Ovarian Cancer**: A patient with advanced ovarian cancer was treated with Oxaliplatin in combination with other chemotherapy drugs. The treatment led to a partial response, and the patient experienced a prolonged progression-free survival.

3. **Gastric Cancer**: A patient with advanced gastric cancer received Oxaliplatin in combination with other chemotherapy drugs. The treatment resulted in a stable disease, and the patient experienced improved quality of life.

Soluções

To ensure the effective and safe use of Oxaliplatin CAS:61825-94-3, it is essential to follow the recommended dosages and administration guidelines. The following solutions can help optimize the treatment:

1. **Monitoring**: Regular monitoring of blood counts, liver function, and renal function is crucial to detect any adverse effects early.

2. **Dose Adjustment**: Adjust the dosage based on the patient's tolerance and response to the treatment.

3. **Supportive Care**: Provide supportive care measures, such as antiemetics, analgesics, and hydration, to manage side effects.

Opiniões de especialistas

Experts recommend the following guidelines for the use of Oxaliplatin CAS:61825-94-3:

1. **Consultation**: Consult with a healthcare professional before starting the treatment to ensure it is appropriate for the patient's condition.

2. **Monitoring**: Regularly monitor the patient's response to the treatment and adjust the dosage as needed.

3. **Adverse Effects**: Be aware of potential adverse effects and manage them promptly to minimize their impact on the patient's quality of life.

FAQs

Here are some frequently asked questions about Oxaliplatin CAS:61825-94-3:

1. **What is Oxaliplatin used for?**
Oxaliplatin is used in the treatment of colorectal cancer, ovarian cancer, and other types of cancer.

2. **How is Oxaliplatin administered?**
Oxaliplatin is typically administered intravenously.

3. **What are the common side effects of Oxaliplatin?**
Common side effects include neuropathy, nausea, vomiting, diarrhea, and fatigue.

Conclusão

Oxaliplatin CAS:61825-94-3 is a valuable chemotherapy drug used in the treatment of various types of cancer. By understanding its parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, users can make informed decisions regarding its use. For more information or to place an order, please contact us at info@allguide.org.

Palavras-chave

Oxaliplatin CAS:61825-94-3, chemotherapy, cancer treatment, colorectal cancer, ovarian cancer, platinum-based drug, case studies, expert opinions, FAQs.